Drug Delivery (Record no. 111313)

000 -LEADER
fixed length control field 03501nam a22005295i 4500
001 - CONTROL NUMBER
control field 978-3-642-00477-3
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20140220084521.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 100316s2010 gw | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783642004773
-- 978-3-642-00477-3
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/978-3-642-00477-3
Source of number or code doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM1-950
072 #7 - SUBJECT CATEGORY CODE
Subject category code MMG
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED071000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615
Edition number 23
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Schäfer-Korting, Monika.
Relator term editor.
245 10 - TITLE STATEMENT
Title Drug Delivery
Medium [electronic resource] /
Statement of responsibility, etc edited by Monika Schäfer-Korting.
264 #1 -
-- Berlin, Heidelberg :
-- Springer Berlin Heidelberg,
-- 2010.
300 ## - PHYSICAL DESCRIPTION
Extent XIV, 501 p.
Other physical details online resource.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
347 ## -
-- text file
-- PDF
-- rda
490 1# - SERIES STATEMENT
Series statement Handbook of Experimental Pharmacology,
International Standard Serial Number 0171-2004 ;
Volume number/sequential designation 197
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Fundamentals -- Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example -- Nanoparticle Technologies for Cancer Therapy -- Biosensing and Drug Delivery at the Microscale -- Devices -- Lipid Nanoparticles: Effect on Bioavailability and Pharmacokinetic Changes -- Viral Vectors for Gene Transfer: Current Status of Gene Therapeutics -- Pulmonary Drug Delivery: Medicines for Inhalation -- Needle-Free Vaccine Injection -- Pharmaceutically Used Polymers: Principles, Structures, and Applications of Pharmaceutical Delivery Systems -- Mucoadhesive Drug Delivery Systems -- Intrauterine Drug Delivery for Contraception and Gynaecological Treatment: Novel Approaches -- Drug-Eluting Medical Implants -- Clinical and Preclinical Application of Therapeutics for Systemic Use -- Improving Oral Delivery -- Transdermal Drug Delivery -- Targeting the Brain – Surmounting or Bypassing the Blood–Brain Barrier -- Clinical and Preclinical Application of Therapeutics for Topical Use -- Carriers in the Topical Treatment of Skin Disease -- Medical Devices for the Treatment of Eye Diseases -- Erratum to: Biosensing and Drug Delivery at the Microscale.
520 ## - SUMMARY, ETC.
Summary, etc In the view of most experts pharmacology is on drugs, targets, and actions. In the context the drug as a rule is seen as an active pharmaceutical ingredient and not as a complex mixture of chemical entities of a well defined structure. Today, we are becoming more and more aware of the fact that delivery of the active compound to the target site is a key. The present volume gives a topical overview on various modern approaches to drug targeting covering today’s options for specific carrier systems allowing successful drug treatment at various sites of the body difficult to address and allowing to increase the benefit-risk-ratio to the optimum possible.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Toxicology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical technology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Dermatology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Neurology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Oncology.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biomedicine.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacology/Toxicology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical Sciences/Technology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Oncology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Dermatology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Neurology.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed edition:
International Standard Book Number 9783642004766
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Handbook of Experimental Pharmacology,
-- 0171-2004 ;
Volume number/sequential designation 197
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-3-642-00477-3
912 ## -
-- ZDB-2-SBL

No items available.

2017 | The Technical University of Kenya Library | +254(020) 2219929, 3341639, 3343672 | library@tukenya.ac.ke | Haile Selassie Avenue